Further investigation of the modifying effect of various chemopreventive agents on apoptosis and cell proliferation in human colon cancer cells
✍ Scribed by Qiao Zheng; Yoshinobu Hirose; Naoki Yoshimi; Akira Murakami; Koichi Koshimizu; Hajime Ohigashi; Keiko Sakata; Yuji Matsumoto; Yoshikatsu Sayama; Hideki Mori
- Publisher
- Springer-Verlag
- Year
- 2002
- Tongue
- English
- Weight
- 278 KB
- Volume
- 128
- Category
- Article
- ISSN
- 1432-1335
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract Tumor necrosis factor‐related apoptosis‐inducing ligand (TRAIL) is a promising cancer therapeutic agent because of its tumor selectivity. TRAIL is known to induce apoptosis in cancer cells but spare most normal cells. In the previous study [Yoo and Lee, 2007], we have reported that hype
## Abstract Scope: Lunasin is an arginine‐glycine‐aspartic acid (RGD) cancer preventive peptide. The objective was to evaluate the potential of lunasin to induce apoptosis in human colon cancer cells and their oxaliplatin‐resistant (OxR) variants, and its effect on the expression of human extracell
Involvement of ornithine decarboxylase (ODC) in proliferation of the HT29 cell line and its control by either fetal calf serum (FCS) or vasoactive intestinal peptide (VIP) as an external signal increasing CAMP level were investigated. Activation of the polyamine-producing system appears to be a nece
## Abstract Naturally occurring molecules with putative cancer chemopreventive properties such as the phytoalexin resveratrol (3,5,4′‐trihydroxystilbene) are lead molecules that guide the design of novel agents with improved pharmacologic properties. The synthetic resveratrol analog 3,4,5,4′‐tetram